Cardiology

Bremelanotide

Q: What does the research say about Bremelanotide?

The scientific consensus on Bremelanotide is unknown. No claims extracted for this topic Based on 0 analyzed claims.

Research on bremelanotide (PT-141), a melanocortin receptor agonist peptide studied for hypoactive sexual desire disorder.

Unknown pathwayAlso known as: Bremelanotide, PT-141, Vyleesi

Claims analyzed

What does the research say about Bremelanotide?

Unknown pathwayBased on 0 claims ( agreements, contradictions)

No claims extracted for this topic

New research on Bremelanotide

Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes

BMC Cancer — Li M — Aug 2005

MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity

Cellular Physiology and Biochemistry — Jing X — Jan 2018

Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways

Cardiovascular Research — Ma J — Oct 2012

Fasudil Protects Against Adriamycin-induced Acute Heart Injury by InhibitingOxidative Stress, Apoptosis, and Cellular Senescence

Evidence brief: Bremelanotide

Bremelanotide (also known as Bremelanotide, PT-141, Vyleesi). Research on bremelanotide (PT-141), a melanocortin receptor agonist peptide studied for hypoactive sexual desire disorder.

As of 2026-08-14, the scientific consensus on Bremelanotide is unknown. No claims extracted for this topic

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-bremelanotide.

Deterministic synthesis from Synapse's enriched corpus — 49 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

Follow the latest Bremelanotide research

Explore every Bremelanotide paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search Bremelanotide papers

Bremelanotide

What does the research say about Bremelanotide?

New research on Bremelanotide

Stay current on Bremelanotide

Evidence brief: Bremelanotide

Follow the latest Bremelanotide research